B Braun Medical Inc Company Profile

✉ Email this page to a colleague

B BRAUN MEDICAL INC has eleven approved drugs.

There are two US patents protecting B BRAUN MEDICAL INC drugs.

There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-nine supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-003	Feb 27, 2024	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	BUPIVACAINE HYDROCHLORIDE	bupivacaine hydrochloride	INJECTABLE;SPINAL	209087-001	Apr 2, 2019	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	ACETAMINOPHEN	acetaminophen	SOLUTION;INTRAVENOUS	204957-001	Feb 18, 2021		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-002	Apr 30, 2015		RX	No	No		⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-001	Feb 27, 2024	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
B Braun Medical Inc	MAGNESIUM SULFATE	magnesium sulfate	INJECTABLE;INJECTION	207967-001	Apr 26, 2021	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Italy	MI20051633	⤷ Sign Up
Japan	2009507807	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2014091420	⤷ Sign Up
Argentina	099443	⤷ Sign Up
South Korea	102162587	⤷ Sign Up
South Korea	20150085131	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1499331	C300615	Netherlands	⤷ Sign Up	PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
2957286	CR 2018 00043	Denmark	⤷ Sign Up	PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721
1499331	13C0055	France	⤷ Sign Up	PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
2365988	2018C/006	Belgium	⤷ Sign Up	PRODUCT NAME: PATIROMER SORBITEX CALCIUM OF EERDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
0984957	C300517	Netherlands	⤷ Sign Up	PRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812
0984957	122012000017	Germany	⤷ Sign Up	PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.